If AI Isn't Making You Money, It's Costing You!

AI should no longer be a "cool technology," but a cash cow. More than just a fancy presentation, its true impact is reflected in the profit and loss statement. So my rule is simple: Any project that doesn't touch the cash flow within 90 days is a cost.

I measure AI projects not by "Is it flashy?" but by "What does the cash register say?" Winning companies share a clear common thread: AI must be integrated into the workflow. Only then is it better managed, has clear metrics, and delivers results within 90 days.

My game plan (3x90): Finish the job in 90 days in 3 stages!

1. Select (Day 0–30):

   Focus on 3 use cases: Revenue based (such as improvement, customization, etc.), Cost-based (such as invoice automation, operational effects, report automation, etc.), Risk-based (such as fraud management, etc.)

   Run a small pilot with real users and validate with A/B testing.

2. Prove It (Days 31–60):

   Be sure to determine 3–4 KPIs and focus on them: conversion rate, average basket value, conversion/transaction time, error-return rate, etc.

   Let the business results speak for themselves, backed by data.

3. Scale (Days 61–90):

   Embed winning flows into effective processes (ERP/CRM/RPA).

   Train the team, look at governance (role, data access, feedback loop).

   Get into a rhythm: start small → prove fast → scale.

Some quick examples (possible in 90 days)

• Sales: Deal scoring + recommendation engine → close ↑

• Marketing: Production cost ↓, customization ↑ → campaign ROI ↑

• Finance: Summarize/analyze time at closing ↓ → decision speed ↑

• Customer Experience: Automatic summary of call notes + “next best step” → resolution time ↓, satisfaction ↑

My golden rule: If we compare AI to a drill, what matters here is not the drill itself, but the hole it creates—that is, the resulting work.

If it doesn't make you win, it makes you lose!

Question: What's the first use case you'll touch in the next 90 days? Leave a comment and I'll share my 3x90 app checklist with anyone who's interested.

Dr. Hakan TETİK